Authors | E Heidemann |
Journal | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
(Strahlenther Onkol)
Vol. 174
Issue 5
Pg. 290-1
(May 1998)
ISSN: 0179-7158 [Print] Germany |
Vernacular Title | Kein Vorteil durch zusätzliche CMF-Behandlung bei nodal positivem, postmenopausalem, Rezeptor-positivem Mammakarzinom unter adjuvanter Tamoxifen-Therapie. |
PMID | 9614963
(Publication Type: Journal Article, Review)
|
Chemical References |
- Tamoxifen
- Cyclophosphamide
- Fluorouracil
- Methotrexate
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Breast Neoplasms
(drug therapy)
- Chemotherapy, Adjuvant
- Cyclophosphamide
(administration & dosage)
- Female
- Fluorouracil
(administration & dosage)
- Humans
- Lymphatic Metastasis
- Methotrexate
(administration & dosage)
- Middle Aged
- Postmenopause
- Prognosis
- Randomized Controlled Trials as Topic
- Tamoxifen
(administration & dosage)
|